Neurocrine is Hiding Ingrezza Hospitalizations

Discussion in 'Neurocrine' started by anonymous, Aug 26, 2019 at 7:04 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    This
     

  2. anonymous

    anonymous Guest

    They stress Long term care to get patients so bad off that the Parkinsonism isn't noticed as much. Just tell the providers that Ingrezza will treat the Parkinsonism too.
     
  3. anonymous

    anonymous Guest

    Take them all off Cogentin and put them on Ingrezza no matter what the movement is.
     
  4. anonymous

    anonymous Guest

    The Motley Fool stock advisor letter recommends Neurocrine as one of their Top ten companies to invest in...YIKES!!! When the shit hits the fan with Ingrezza, a lot of investors will be laying in the fetal position underneath their desks, crying....
     
  5. anonymous

    anonymous Guest

    Time to BUY then.
     
  6. anonymous

    anonymous Guest

    Tell them Ingrezza prolongs life by 100 years and it should be put in the water.
     
  7. anonymous

    anonymous Guest

    Let's all lie, why not? We are only dealing with patient's lives!! Money is the only thing that matters. Looks like everyone is on the same page with me!!
     
  8. anonymous

    anonymous Guest

    We already do by hiding data and white washing over physicians questions to save market share.
     
  9. anonymous

    anonymous Guest

    Screw the patients and just give me my bonus. Ingrezza is a cure all for anything I can make up and I'm leaving no stones un-turned in any office I walk into. My docs are writing this stuff left and right.
     
  10. anonymous

    anonymous Guest

    WOW to the above post, but true. Its all about that year end bonus baby!
     
  11. anonymous

    anonymous Guest

    If you get complaints of Parkinsonism with Ingrezza, just tell the docs to increase the dose to bid. They will believe it.
     
  12. anonymous

    anonymous Guest

    WWG1WGA